PHARMACEUTICAL COMPOSITIONS IN FORM OF TABLET OR COATED TABLET CONTAINING MOISTURE-, HEAT- AND LIGHT-SENSITIVE ACTIVE SUBSTANCES, HAVING A MONOCLINIC CRYSTALLINE STUCTURE

PHARMACEUTICAL COMPOSITIONS IN FORM OF TABLET OR COATED TABLET CONTAINING MOISTURE-, HEAT- AND LIGHT-SENSITIVE ACTIVE SUBSTANCES, HAVING A MONOCLINIC CRYSTALLINE STUCTURE

Pharmaceutical compositions in form of tablets or coated tablets contain moisture-, heat- and light-sensitive active substances having a monoclinic crystalline structure. These pharmaceutical preparations contain an active substance together with 0,2 up to 1,5 part closed to water-free salt of alkal...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BEKE KATALIN, MATHE TIBOR, SIMO MARGIT, ORBAN ERNO, BOBAK DOROTTYA, KOVACS CHRISTIAN, MAROSSY KATALIN, BACSA GYORGY, SZENDREI LEVENTE, LANGO JOZSEF, SZILAGYI JUDIT, JANCSO SANDOR, BIBLO MARGIT
Format: Patent
Sprache:eng ; slo
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Pharmaceutical compositions in form of tablets or coated tablets contain moisture-, heat- and light-sensitive active substances having a monoclinic crystalline structure. These pharmaceutical preparations contain an active substance together with 0,2 up to 1,5 part closed to water-free salt of alkaline earth metal and 0,5 up to 2,5 weight parts of microcrystaline cellulose, computed related to the active substance together with one or two or more carriers and / or additives suitable from pharmaceutical point of view. The salts playing role of the above mentioned alkaline earths may be hydrogenphosphate, dihydrogenphosphate, calcium hydrogencarbonate calcium sulphate or magnesium sulphate.